跳至主要内容
临床试验/CTRI/2025/12/098418
CTRI/2025/12/098418尚未招募2 期

Randomized open labelled controlled clinical trial to evaluate the efficacy of Doorvadi Taila Vikeshika dressing in the management of Dushta Vrana with special reference to Traumatic Infected Wound.

Government Ayurved college Nanded1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
reducing size of wound or complete healing of wound in 28days

研究概览

简要总结

The Prevalence of wounds is 15.03 per 1000. The Prevalences of Acute and Chronic wounds were 10.55 and 4.48 per 1000 of the Population respectively.

To avoid the higher systemic and local complications caused by infected wound.

To avoid surgical interventions like debridement of wound which is invasive and painful treatment.

Doorva, Daruharidra, tila taila production is on very large amount in India so we can make cost effective wound care product from it.

Vikeshika dressing has easy application for wound management.

We need more Ayurvedic local drug applications on wound which should be Cost effective, Non- invasive, Not causing any side effect, easily available to all Socio-economic classes.

To cope up with other Pathies it is need of the hour for Ayurveda to make evidence-based medicine in such diseases for universal acquiescence. And to prove valuable hidden treasures of Ayurveda literature Samhitas as source of evidence-based research in Samhita kaal.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Infected Abrasion/Laceration/Incised Traumatic infected wound.
  • 150 Patients with dushta vrana (Traumatic infected wound) of more than seven days duration.
  • Patients irrespective of gender, religion, occupation and socio-economic status will be selected.
  • Age – 18 to 60 years.

排除标准

  • Patients suffering from systemic illnesses like DM, HTN, TB, HIV, HBsAg positive, Leprosy, Syphilis, venous ulcer, Arterial ulcer, Malignancy.
  • Patients suffering from gangrene, burns, sepsis.
  • Patients with bleeding disorders.
  • Patients having other organic/infectious illness.
  • Any other acute illness.

结局指标

主要结局

reducing size of wound or complete healing of wound in 28days

时间窗: 28 days

次要结局

  • healing of wound and associate symptoms.(follow up on 0,7,14,21,28 days and final assessment on 28 day)
  • To study the shodhan and ropan effect of Doorvadi Taila Vikeshika(dressing in management of dushta vrana.)

研究者

发起方
Government Ayurved college Nanded
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Ankita Ashokrao Sulkekar

Government Ayurved College, Nanded

研究点 (1)

Loading locations...

相似试验